. Author manuscript; available in PMC: 2009 Sep 11.

Published in final edited form as: Med Phys. 2007 Aug;34(8):3334–3344. doi: 10.1118/1.2756612

Table III.

Estimation of the statistical significance in the difference between the FROC performance of the unilateral and bilateral CAD systems on test subsets 1 and 2. The FP rates of the FROC curves were estimated from the no-mass data set: (a) all cases and (b) malignant cases.

(a)		FOM (JAFROC)
		Test subset 1	Test subset 2
	Unilateral CAD	0.52	0.48
	Bilateral CAD	0.58	0.51
	p value	<0.001	0.008
(b)	FOM (JAFROC)
		Test subset 1 (malignant only)	Test subset 2 (malignant only)

	Unilateral CAD	0.56	0.53
	Bilateral CAD	0.61	0.56
	p value	0.009	0.003